Encorium Group, a clinical research organization, has appointed Sari Laitinen to its board of directors.
Ms Laitinen will replace Jyrki Mattila who has rendered his resignation from the company's board of directors.
Ms Laitinen will serve as the chair of the nominating committee and as a member of the audit and executive compensation committees.
With the appointment of Ms Laitinen, Encorium's board of directors will remain at five members and will consist of a majority of independent directors.
Ms Laitinen is the founder and owner of Sari Laitinen, US Legal Counsel, a US legal services firm established in 2006 in Espoo, Finland. Prior to 2006, Ms Laitinen served as director of US capital markets with Ernst & Young Oy based in Helsinki, Finland.
Kai Lindevall, executive chairman of Encorium Group, said: "We are very pleased to be able to add someone of Ms Laitinen's caliber to our board of directors. Her significant legal and capital markets expertise both in the US and in Finland will be very beneficial to Encorium and we look forward to benefiting from her strategic counsel."